BioPharm International
November 15, 2003
Product Development
16
11
After many starts and stops, hype and disappointment, foreign protein expression in plants is now routine and biopharmaceuticals produced in green plants will soon be with us.
November 01, 2003
Product Development
16
11
Chitosan and alginate hydrogels are high-molecular-weight carbohydrate polymers used in an extensive array of pharmaceutical applications. While many applications depend upon the ionized state of the polymer, other factors play an important role in the pharmacological activity of complexes that include these agents.
November 01, 2003
Columns and Departments
16
11
One goal of FDA's initiative to overhaul how it ensures high-quality pharmaceutical production is to apply more oversight and stricter rules to higher-risk products and processes (Inside Washington, October 2003).
November 01, 2003
International BioMarket
16
11
UK science expertise, backed by increased government funding, has led to a thriving bioscience industry, distinguished by the energy and creativity of its entrepreneurs." These words are not mine but those of Lord David Sainsbury, the British government's science and innovation minister.
November 01, 2003
Quality Management
16
11
Biopharmaceutical products in storage change as they age, but they are considered to be stable as long as their characteristics remain within the manufacturer's specifications. The number of days that the product remains stable at the recommended storage conditions is referred to as the shelf life.
November 01, 2003
Columns and Departments
16
11
In a tale of two markets, shares in biopharm companies bounce back.
November 01, 2003
Columns and Departments
16
11
As FDA tries to bring pharmaceutical manufacturing into the 21st century, changes are likely to favor companies with greater manufacturing expertise and the means to invest in new technoglogies.